Nanopublications

@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RA-SgNkbxNaUjzG2urhUzqWT0slTx7mGl1mV4qaS3cVeg> .
@prefix sub: <http://purl.org/np/RA-SgNkbxNaUjzG2urhUzqWT0slTx7mGl1mV4qaS3cVeg#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix orcid: <https://orcid.org/> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix schema: <https://schema.org/> .
@prefix nkg: <https://w3id.org/neurodkg/> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_0050561> schema:possibleTreatment sub:medtherapy .
  sub:medtherapy prov:wasDerivedFrom sub:quote ;
    schema:drug <http://identifiers.org/drugbank/DB00949> ;
    schema:targetPopulation sub:targetpop ;
    nkg:indicationType nkg:AdjunctiveTherapy .
  sub:quote prov:value "If these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgment, felbamate oral suspension can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children" ;
    prov:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37> .
}

sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0003-4665-7473 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCC0CnI6yMUipkXh7RB8b/9rRnO8+qDR+pJVf//jGV0r2nd7JcvWFkhPN/eLja/pUw/+nvTE24rhKqK/jWxppJLoka+bk57wrYw43DrSbzQWoJc3ImWe3d08jSYt3mh3uOLWKciogBaonJUBohJsqhTmOULevIPONTZOMzeOJTWwQIDAQAB" ;
    npx:hasSignature "Np6Uwkyf6L8HIdLXMPyCmaFNdI32cfLrTmPFRAaq4wUZjWwpO8NRwTJxg4C74+aThPzjofbpNoOAMVsZVaETIgrypad16FyM6U5KPe4HkcQqdJmenhx2DyV0PjgfSDGRMez9KaGGqxizSuEMPnOjbA2p16ATilJukKxPeSyaQnY=" ;
    npx:hasSignatureTarget this: .
  this: dcterms:created "2021-04-05T15:18:27.533+02:00"^^xsd:dateTime ;
    dcterms:creator orcid:0000-0003-4665-7473 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA64ptuigOfVGfIhpdwWeJnssaHV9jTQCnAm6Pvgrvmos> .
}